News

A new study from researchers at Wake Forest University School of Medicine shows an improvement in screening rates for anxiety ...
NeuroPace's RNS System trial showed a strong safety profile and subgroup efficacy in drug-resistant epilepsy, prompting FDA ...
A UCSF-led study using ESO data found EMS providers often failed to recognize status epilepticus during prehospital care, ...
SK Life Science is encouraging patients beetling down the long and winding road toward seizure-free life to switch gears. In ...
SK Life Science launched its latest DTC advertising campaign for its seizure medication. 1 Road to Reduction is an ...
HealthDay News — For patients with diffuse gliomas, tumor-related epilepsy (TRE) is not a strong prognostic factor, according to a study published in the May issue of Brain and Behavior.
Upon his arrival at Fortis Hospital, Bannerghatta Road, the doctors meticulously evaluated his condition. While studying the ...